KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd
’s (MGRC) wholly-owned subsidiary MGRC Therapeutics Sdn Bhd (MGRCT) has entered a memorandum of understanding (MoU) with Twistcode Technologies Sdn Bhd.
In a statement, MGRC said the collaboration will focus on the bioinformatics enhanced-accelerated services terminal (B.E.A.S.T), a cutting-edge platform designed to revolutionise bioinformatics services across Malaysia and the Middle East.
